๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Adverse Event

Checkpoint Inhibitor-induced Liver Injury NCT04476563n/a1 site๐Ÿ“ Nottingham University of Nottingham ยท Tests: Obtaining biological samples To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer NCT06039644NA1 site๐Ÿ“ Taipei GenMont Biotech Incorporation ยท Tests: Probiotic, Placebo DOAC in Chinese Patients With Atrial Fibrillation NCT05378035n/a1 site๐Ÿ“ Hong Kong Chinese University of Hong Kong ยท Tests: Blood Tests This Study Examines Whether Personality Traits Influence the Frequency or Severity of Ocular Adverse Effects Reported by Patients Using Glaucoma Medications. The Findings May Identify Patients at Greater Risk of Intolerance and Support More Personalized Treatment and Counselling. NCT07739784n/a1 site๐Ÿ“ Montreal McGill University Health Centre/Research Institute of the Mโ€ฆ ยท Tests: No Interventions IPGx PILOT Whole Genome Sequencing Extension Cohort NCT06766071n/a1 site๐Ÿ“ Bryan Texas A&M University Comparing Traditional Risk Scores and an AI-Based Multimodal Model for Predicting Cardiovascular Events After Gastrointestinal Surgery NCT07539532n/a1 site๐Ÿ“ Hร  Nแป™i Bach Mai Hospital A Study to Evaluate the Efficacy and Safety of BX-001N in Preventing Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Major Adverse Kidney Events (MAKE) NCT07164833Phase 28 sites๐Ÿ“ Daegu๐Ÿ“ Seongnam๐Ÿ“ Seoul Bilix Co.,Ltd. ยท Tests: BX-001N Experimental group 1, BX-001N Experimental group 2, Placebo group 1, Placebo group 2 Development and Validation of a Personalized Digital Healthcare Model for Managing Side Effects in Breast Cancer Survivors NCT06729684NA1 site๐Ÿ“ Seoul Samsung Medical Center ยท Tests: digital health (application and smartwatch) Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) NCT07761910Phase 21 site๐Ÿ“ Indianapolis Indiana University ยท Tests: PET/CT 18F-Flurpiridaz Rest/Stress Test, Coronary CT Angiography (CCTA), 18F-Flurpiridaz Multi-modal Adverse Events Prediction for Premature Coronary Heart Disease Trial: MAP-CHD Trial NCT07004452n/a1 site๐Ÿ“ Beijing China National Center for Cardiovascular Diseases Observational Study to Develop a Predictive Score for Adverse Events Post ERCP NCT06776874n/a1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Effects of Remimazolam and Ciprofol TIVA on PRAE in Pediatric Tonsillectomy and Adenoidectomy NCT07118579Phase 41 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: Remimazolam, Propofol, Ciprofol A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis NCT07189325Phase 31 site๐Ÿ“ Montpellier University Hospital, Montpellier ยท Tests: Platform therapies (Dimethyl Fumarate, Teriflunomide, Glatiramer Acetate, Beta-interferons), Anti-CD20 therapies (Ocrelโ€ฆ A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity NCT07291232Phase 12 sites๐Ÿ“ Anaheim๐Ÿ“ Grayslake AbbVie ยท Tests: ABBV-295, Placebo Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair NCT07226791Phase 213 sites๐Ÿ“ Riverside๐Ÿ“ Jacksonville๐Ÿ“ Miami AbbVie ยท Tests: AGN-151607-DP, Placebo for AGN-151607-DP Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients NCT07114627n/a1 site๐Ÿ“ Rotterdam Erasmus Medical Center ยท Tests: Blood sampling for pharmacokinetics Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) NCT03297281NA1 site๐Ÿ“ Toulouse Clinique Pasteur ยท Tests: Maintenance of OAC in surgery of BPH by PVP., Discontinuation of OAC in surgery of BPH by PVP. OPTIMIZE 5.5 - Optimizing Impella 5.5 Outcomes Through Advanced Data Science NCT07619144n/a1 site๐Ÿ“ Vienna Medical University of Vienna ยท Tests: Micro-axial flow pump support A Study of GC101 TIL in Advanced Breast Cancer (10hospital) NCT05142475EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Juncell Therapeutics ยท Tests: Tumor Infiltrating Lymphocytes (TIL) Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial NCT06470971Phase 21 site๐Ÿ“ Columbus Yuanquan Yang ยท Tests: Anti-PD-L1 Monoclonal Antibody, Anti-PD1 Monoclonal Antibody, Biopsy, Biospecimen Collection, Bone Scan Multi-Agent Collaborative ADR Prediction With Human-Machine Decision Comparison NCT07808866n/a2 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Peking University Third Hospital ยท Tests: Retrospective medical record data analysis only, no clinical intervention Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care NCT03882580n/a3 sites๐Ÿ“ Paris๐Ÿ“ Paris๐Ÿ“ Paris Groupe Hospitalier Pitie-Salpetriere ยท Tests: Anti-Cancer Agents Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. NCT07157670n/a1 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer NCT05874297NA1 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Best Practice, Internet-Based Intervention, Questionnaire Administration Case-Specific Health Care Professional Clinical Survey of Liberantโ„ข Thrombectomy System NCT07335341n/a4 sites๐Ÿ“ Washington D.C.๐Ÿ“ Naples๐Ÿ“ New York Medtronic Endovascular ยท Tests: Liberant Thrombectomy System The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity NCT06214195Phase 31 site๐Ÿ“ Hangzhou Zhejiang Cancer Hospital ยท Tests: Shengmai San (ingredients include ginseng, Ophiopogon japonicus, and Schisandra chinensis) Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Cancer Treatment NCT06816095n/a1 site๐Ÿ“ Las Palmas Bernardino Clavo, MD, PhD A Clinical Study on TIL for the Treatment of Advanced Solid Tumors NCT05087745EARLY Phase 11 site๐Ÿ“ Hangzhou Shanghai Juncell Therapeutics ยท Tests: Tumor Infiltrating Lymphocytes Applying a Multidisciplinary Intervention for Drug Adequacy in an Intermediate Care Hospital (AMIDA-ICH) NCT07015112NA1 site๐Ÿ“ Barcelona Parc Sanitari Pere Virgili ยท Tests: Patient-centered multidisciplinary treatment review Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer NCT06613165n/a1 site๐Ÿ“ Xi'an Xijing Hospital
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy